Imprimis Pharmaceuticals has announced the release of data from a peer-reviewed study of patients receiving Tri-Moxi-Vanc Dropless Therapy (triamcinolone acetonide...
In this review, we delve into BsAbs in B-NHL from the preclinical development to clinical data in both refractory and frontline settings, and then discuss future perspectives.
We aimed to compare a single-inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium (BDP/FF/G) versus a single-inhaler dual bronchodilator combination of indacaterol plus glycopyrronium (IND/GLY)...
Recommended clinical indications: Control of hypothyroidism, congenital hypothyroidism in infants , acquired hypothyroidism in children and juvenile myxoedema.